CoChat

TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Abstract

Purpose Personalized medicine has largely failed to produce curative therapies in advanced cancer patients. Evaluation of in situ drug target availability (DTA) concomitant with local protein expression is critical to an accurate assessment of therapeutic efficacy, but tools capable of both are currently lacking.Procedure We developed and optimized a fluorescence imaging platform termed TRIPODD (Therapeutic Response Imaging through Proteomic and Optical Drug Distribution), resulting in the only methodology capable of simultaneous quantification of single-cell DTA and protein expression with preserved spatial context within a tumor. Using TRIPODD, we demonstrate the feasibility of combining two complementary fluorescence imaging techniques, intracellular paired agent imaging (iPAI) and cyclic immunofluorescence (cyCIF), conducted with oligonucleotide-conjugated antibodies (Ab-oligos) on tissue samples.Results We successfully performed sequential imaging on a single tissue section of iPAI to capture single-cell DTA and local protein expression heterogeneity using Ab-oligo cyCIF. Fluorescence imaging data acquisition was followed by spatial registration resulting in high dimensional data correlating DTA to protein expression at the single-cell level where uptake of a targeted probe alone was not well correlated to protein expression.Conclusion Herein, we demonstrated the utility of TRIPODD as a powerful imaging platform capable of interpreting tumor heterogeneity for a mechanistic understanding of therapeutic response and resistance through quantification of drug target availability and proteomic response with preserved spatial context at single-cell resolution.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11307-021-01589-x

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 71 references

Research works printed but not linked: 1

  1. Chang YH et al. (2017) In 2017 39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) 672-675

Cited by

See all 9

Metadata

Authors
McMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L.
Affiliations
  • Oregon Health & Science University (US)
  • Dartmouth College (US)
  • Illinois Institute of Technology (US)
Corresponding author
Gibbs, Summer L.
Venue
Molecular Imaging and Biology
Published
2021-03-09
Volume
23
Issue
5
Pages
650-664
ISSN
  • 1536-1632 (ISSN-L)
  • 1860-2002
OpenAlex
W3135752685
Cited by
8
References
71
Citations by year
2026: 2 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1
FWCI
0.68
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Molecular Imaging and Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Mark Foundation For Cancer Research (ASPIRE Award)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Advanced Fluorescence Microscopy Techniques
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Optical Imaging and Spectroscopy Techniques
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
drug distribution, treatment response, cyclic immunofluorescence, single-cell imaging, tumor heterogeneity, spatial registration, cancer therapy resistance, in situ proteomics
MeSH terms
Animals, Antineoplastic Agents, Cell Survival, Female, Fluorescent Dyes, Humans, Male, Mice, Nude, Neoplasms, Drug Delivery Systems, Intracellular Space, Cell Line, Tumor, Mice, Molecular Imaging, Precision Medicine, Optical Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response. https://app.cochat.ai/papers/10.1007/s11307-021-01589-x
The paper
McMahon, N. P., Solanki, A., Wang, L. G., Montaño, A. R., Jones, J. A., Samkoe, K. S., Tichauer, K. M., & Gibbs, S. L. (2021). TRIPODD: a Novel Fluorescence Imaging Platform for In Situ Quantification of Drug Distribution and Therapeutic Response. Molecular Imaging and Biology. https://doi.org/10.1007/s11307-021-01589-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.